Avraham Hampel
Corporate Officer/Principal en STEAKHOLDER FOODS LTD. .
Perfil
Avraham Hampel is currently the Secretary at BioCancell Therapeutics, Inc. and the Vice President-Corporate Development at Steakholder Foods Ltd.
He previously worked as a Secretary at Anchiano Therapeutics Ltd.
Cargos activos de Avraham Hampel
| Empresas | Cargo | Inicio |
|---|---|---|
| STEAKHOLDER FOODS LTD. | Corporate Officer/Principal | 01/09/2020 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Secretario Corporativo | 14/08/2009 |
Antiguos cargos conocidos de Avraham Hampel.
| Empresas | Cargo | Fin |
|---|---|---|
| ANCHIANO THERAPEUTICS LTD. | Secretario Corporativo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| STEAKHOLDER FOODS LTD. | Consumer Non-Durables |
| Empresas privadas | 2 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Avraham Hampel
